In mounting woes for Monsanto, Competition Commission has ordered another detailed probe against the genetically-modified seed major for alleged unfair business practices.
This is the third time this year that CCI is ordering a probe against the company and the latest one is based on a complaint filed by Hyderabad-based Amar Biotech pertaining to Sub-Licensing Agreement (SLA).
The latest complaint was filed against Mahyco Monsanto Biotech (India) Ltd, Monsanto Holdings Pvt Ltd, Monsanto Company and Maharashtra Hybrid Seeds Company Ltd.
Ordering the probe, Competition Commission of India (CCI) said that in the present case, “the SLA was not extended/ renewed by Opposite Party 1 (Mahyco Monsanto Biotech) after efflux of time”.
Full Content: Financial Express
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Massachusetts AG Sues Insulin Makers and PBMs Over Alleged Price-Fixing Scheme
Jan 14, 2025 by
CPI
Apple and Amazon Avoid Mass Lawsuit in UK Over Alleged Collusion
Jan 14, 2025 by
CPI
Top Agent Network Drops Antitrust Suit Against National Association of Realtors
Jan 14, 2025 by
CPI
Weil, Gotshal & Manges Strengthens Antitrust Practice with New Partner
Jan 14, 2025 by
CPI
Russian Court Imposes Hefty Fine on Google for Non-Compliance with Content Removal Orders
Jan 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand